Ayinalem Alemu1, Zebenay Workneh Bitew2, Teshager Worku3. 1. Ethiopian Public Health Institute, Addis Ababa, Ethiopia. Electronic address: ayinalemal@gmail.com. 2. St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. Electronic address: zedo2015@gmail.com. 3. Haramaya University, College of Health and Medical Sciences, Harar, Ethiopia. Electronic address: teshager.kassie@gmail.com.
Abstract
OBJECTIVE: To assess poor treatment outcomes and its predictors among drug-resistant tuberculosis patients treated in Ethiopia. METHODS: Data were searched from both electronic databases and other sources. From the whole search, 404 articles reviewed and 17 articles that fulfilled the inclusion criteria included in the analysis. Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was followed and Joanna Briggs Institute Critical Appraisal checklist used for assessing the quality. Risk of bias assessed using forest plot and Egger's regression test. Data were analyzed using STATA version 15 and Review Manager Software version 5.3. RESULTS: The overall pooled proportion of poor treatment outcome and mortality was 17.86% and 15.13% respectively. The incidence density rate of poor treatment outcome and mortality was 10.41/1000 person-months and 9.28/1000 person-months respectively. Survival status and successful treatment outcomes were 76.97% and 63.82% respectively. HIV positivity, non-HIV comorbidities, clinical complications, extrapulmonary involvement, undernutrition, anemia, treatment delay, lower body weight, and older age were the predictors of poor treatment outcome. CONCLUSION: Better survival and treatment success rates noted in Ethiopia as compared to the global average. The majority of the poor treatment outcomes occurred within the intensive phase. Early initiation of anti-tuberculosis treatment would be important for successful treatment outcomes.
OBJECTIVE: To assess poor treatment outcomes and its predictors among drug-resistant tuberculosispatients treated in Ethiopia. METHODS: Data were searched from both electronic databases and other sources. From the whole search, 404 articles reviewed and 17 articles that fulfilled the inclusion criteria included in the analysis. Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was followed and Joanna Briggs Institute Critical Appraisal checklist used for assessing the quality. Risk of bias assessed using forest plot and Egger's regression test. Data were analyzed using STATA version 15 and Review Manager Software version 5.3. RESULTS: The overall pooled proportion of poor treatment outcome and mortality was 17.86% and 15.13% respectively. The incidence density rate of poor treatment outcome and mortality was 10.41/1000 person-months and 9.28/1000 person-months respectively. Survival status and successful treatment outcomes were 76.97% and 63.82% respectively. HIV positivity, non-HIV comorbidities, clinical complications, extrapulmonary involvement, undernutrition, anemia, treatment delay, lower body weight, and older age were the predictors of poor treatment outcome. CONCLUSION: Better survival and treatment success rates noted in Ethiopia as compared to the global average. The majority of the poor treatment outcomes occurred within the intensive phase. Early initiation of anti-tuberculosis treatment would be important for successful treatment outcomes.
Authors: D M Kokebu; S Ahmed; R Moodliar; C-Y Chiang; G Torrea; A Van Deun; R L Goodall; I D Rusen; S K Meredith; A J Nunn Journal: Int J Tuberc Lung Dis Date: 2022-08-01 Impact factor: 3.427
Authors: Farman Ullah Khan; Asim Ur Rehman; Faiz Ullah Khan; Khezar Hayat; Amjad Khan; Nafees Ahmad; Jie Chang; Usman Rashid Malik; Yu Fang Journal: Int J Environ Res Public Health Date: 2022-01-29 Impact factor: 3.390
Authors: Abdurahman Abibeker Omer; Meiraf Daniel Meshesha; Abraham Teka Ajema; Samuel D Yoo Journal: Infect Drug Resist Date: 2022-08-22 Impact factor: 4.177